Wednesday, June 30, 2021

Health Canada Issues Yet Another Covid Vaccine Warning- Pfizer and Moderna: Inflamming Hearts Globally

  


 

 Interesting that Health Canada chooses the evening before Canada Day and the extra long week end (most people will have) to issue yet another warning of yet another serious Covid Vaccine effect.

 One that is and has been much more common then the always spinning media has led you to believe. Same as the VITT's. Recall when the blood clots were like one in a million? Then they became one in 55,000. Rare became more common. 

So, here we are with the Covid vaccine damaging hearts globally- you've been told.  This effect from the vaccine has been written about here for some time. But will you be informed/ warned before you take the jab?  
 
Informed Consent? Have you exercised it? Really? Bet you didn't!

Health Canada has updated the labels for the Pfizer-BioNTech and Moderna COVID-19 vaccines to include information on the very rare  (not so rare) reports of myocarditis and pericarditis following vaccination.

Myocarditis, or inflammation of the heart muscle, and pericarditis, which is inflammation of the tissue surrounding the heart, following vaccination have been reported in a small number of people in Canada and internationally, according to Health Canada.

Symptoms include chest pain, shortness of breath or the feeling of having a fast-beating, fluttering or pounding heart (palpitations). Health Canada recommends people seek immediate medical attention if they experience any of those symptoms within several days following vaccination.

Health Canada and other international regulators are “continuing to investigate the potential relationship between COVID-19 vaccines and these rare events. Most reported cases to date have followed vaccination with an mRNA vaccine (Pfizer-BioNTech and Moderna) and, based on an analysis of international cases, have occurred more often after the second dose and in younger male adults and adolescents,” according to the release.

The short-term data available has shown that the adverse effects were “typically (but not always) mild and treatable,” Health Canada said. The health agency added that Canadian data is expected to evolve as more people in these populations are vaccinated. Data on long-term outcomes is not available yet.

Previous reports:

Long Covid may be 100 times less common than scientific studies suggest, according to GP records

Earlier: 

Long Covid:

 We’ve all seen the term bandied about endlessly. If you don’t want “short” covid you sure as heck don’t want “long covid” It’s the covid that goes on and on and on. Terrifying. And the very idea of it's existence was meant to be terrifying. “Long covid” and claims of it’s abundance have always been a question in my mind. Seemed improbable, highly suspect and most probably just more fear porn.

Long Covid may be 100 times less common than scientific studies suggest, according to GP records

GP records show 23,000 recorded cases of the illness, not 2 million, leading to questions over how the gap arose

Yes, how could such a gap have arose? A gap that is 100 times the size of the real data?

Long Covid may be much less common than previously feared, after an analysis of GP records found official cases of the condition were barely one hundredth the level suggested by scientific studies.

The most significant scientific study, known as REACT and published last week, indicated that about 2 million people in the UK currently have the condition and that 38 per cent of Covid patients have symptoms lasting at least 12 weeks.

 Science or spin? The question always has to be asked. Because science is in a sad, sad state of affairs.

By contrast, a “pseudonymised” analysis of 57.9 million GP records in England has found only 23,273 cases ever formally recorded between February 2020 and April 2021, in a sample covering 96 per cent of the population.
                       
“We were very surprised to see almost a hundred-fold difference in prevalence between population survey estimates and formally recorded diagnoses for the same condition,” said Ben Goldacre, of Oxford University.
“Good data on Long Covid will be crucial for research into the prevalence of Long Covid, its causes and consequences, and to plan services effectively,” he said.

If "Long Covid" doesn't exist, and that seems to be the case, then research for it can't exist either? And research dollars can't be garnered by universities from pharma corporations. Never mind the big pharma profits that can't be made. Oh the disgruntled shareholders. Woe is them..

Capillary leak syndrome potential side-effect of AstraZeneca vaccine: Heath Canada

So the main stream media is finally catching up to the reports of this potentially deadly Covid vaccine effect.  

Reported here two weeks ago:

Canada’s Covid Vaccine Weekly Death and Injury Report- Data Lags, Vaccine Injury and Death Increase & Capillary Leak Syndrome

 One wonders when the news below will get more mainstream coverage?

*4  Guillain- Barre Syndrome is occurring in higher numbers then would normally be expected- 

GB Syndrome is occurring at ten times the anticipated rate.

Rare Neurological Disorder – Guillain-Barré Syndrome – Following COVID-19 Vaccination

The frequency of Guillain-Barré syndrome in these areas was estimated to be up to 10 times greater than expected.

There are 28 cases in Canada according to the latest, always lagging, data. See here

 CityTVNews

Health Canada is updating the label for the Oxford-AstraZeneca and COVISHIELD COVID-19 vaccines to add capillary leak syndrome as a potential side-effect.

The agency is also including a warning for patients with a history of the ailment to not get those vaccines.

Capillary leak syndrome is a very rare, serious condition that causes fluid leakage from small blood vessels (capillaries), which can result in the swelling of the arms and legs, sudden weight gain, low blood pressure, thickening of the blood and low levels of the albumin blood protein.

Health Canada and the Public Health Agency of Canada have been monitoring the condition since it was raised as a potential safety concern by the European Medicines Agency in April.

Earlier this month, the EU drug regulator said it reviewed cases of six people who had capillary leak syndrome after they had received a shot of the AstraZeneca vaccine, out of 78 million doses of the AstraZeneca and COVISHIELD vaccines administered in Europe and the United Kingdom as of May 27, 2021.

There has been one case of capillary leak syndrome following vaccination with the AstraZeneca or COVISHIELD COVID-19 vaccine reported in Canada as of June 11th.

 

 

Tuesday, June 29, 2021